+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cancer Stem Cells Market - Global Forecast 2025-2030- Product Image
Cancer Stem Cells Market - Global Forecast 2025-2030- Product Image
Sale

Cancer Stem Cells Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 192 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5977964
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Cancer stem cell research is emerging as a priority focus in oncology, driven by a need for solutions that tackle tumor resistance, relapse, and targeted therapy development. Senior leaders in the life sciences and healthcare sectors are re-evaluating their strategic approaches to capture the value presented by advancements in cancer stem cell markets and technologies.

Market Snapshot: Cancer Stem Cells Market Growth Trajectory

The cancer stem cells market grew from USD 5.21 billion in 2024 to USD 5.77 billion in 2025. It is expected to expand at a CAGR of 10.61%, reaching USD 9.55 billion by 2030. This growth reflects increasing demand for novel cancer therapies, robust investment in R&D, and the integration of advanced research tools. The landscape is being shaped by technological advancements, market entry of innovative service providers, and increased adoption of precision medicine approaches. Across segments and geographic regions, demand drivers remain strong, further advancing the role of cancer stem cells in therapeutic development.

Scope & Segmentation

This report provides an in-depth analysis, forecasting revenue and evaluating key trends across the cancer stem cells sector.

  • Product Types: Instruments (cell sorters, flow cytometers, imaging systems), reagents and kits (culture media and supplements, growth factors and cytokines, markers and antibodies), and services (contract research, custom assay development).
  • Applications: Cell therapy research (clinical trials, preclinical evaluation), disease modeling (in vitro and in vivo), drug discovery (high throughput screening, lead optimization), and toxicology testing (genotoxicity, in vitro toxicity).
  • End Users: Academic and research institutes (research institutes, university labs), biopharmaceutical companies (large pharma, small biotech), contract research organizations (clinical and preclinical services), and hospitals and clinics.
  • Regions Covered: Americas (United States: California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Key Companies: Thermo Fisher Scientific, Merck KGaA, Bio-Techne, STEMCELL Technologies, Miltenyi Biotec, Lonza Group, PromoCell, Abcam, Celprogen, and American Type Culture Collection (ATCC).

Technologies & Segment Relevance

Advanced instruments and reagents support precise cancer stem cell isolation, characterization, and manipulation. The growing importance of AI-enabled data analysis and microfluidic systems is increasing efficiency in biomarker discovery and candidate screening. Service providers play a pivotal role by offering customized research solutions that bridge discovery and clinical utility. Regional expertise and infrastructure contribute to the scalability of innovative platforms and reinforce the impact of this market on global oncology pipelines.

Key Takeaways: Strategic Insights for Cancer Stem Cells Market

  • Precision technologies, such as single-cell sequencing and organoid culture systems, are enabling detailed investigations into cellular heterogeneity and functional pathways.
  • Collaborative models, including cross-industry partnerships and consortium-based research, are accelerating the transition from basic discovery to clinical translation.
  • Adoption of automated workflows and AI-driven analytical suites is streamlining experimental throughput and improving predictive accuracy for targeted therapies.
  • Regulatory dynamics, including evolving policy frameworks, require adaptive strategies to sustain compliance and speed-to-market in diverse regions.
  • Segmentation analysis highlights the importance of offering specialized instruments, assay kits, and contract services to meet diverse end-user requirements.
  • Regional ecosystems and localized production are becoming essential to mitigate logistical risks and foster resilience in supply chains.

Tariff Impact: Navigating Supply Chain & Collaboration Challenges

Recent United States tariff adjustments have increased the cost and lead times for advanced laboratory equipment and critical reagents relevant to cancer stem cell research. These pressures are prompting both academic and commercial laboratories to diversify supplier portfolios, renegotiate contracts, and invest in domestic manufacturing capacity. Collaborative networks are adapting with new risk management strategies and pricing models, ensuring research progress continues despite evolving trade landscapes.

Methodology & Data Sources

Analysis is built on robust secondary research across peer-reviewed journals, patents, regulatory filings, and academic reports. Primary insights were gathered through interviews with senior R&D and opinion leaders, cross-referenced with industry event data and clinical trial registries. Trend assessments, thematic coding, and regional comparisons ensure a balanced, validated market view.

Why This Report Matters

  • Empowers strategic decision-making by delivering actionable intelligence tailored for investment prioritization and partnership selection.
  • Clarifies the most critical technology trends and policy shifts impacting operational resilience and commercial growth in the cancer stem cell market.
  • Provides a region- and segment-focused view, giving decision-makers an advantage in global competitive strategy.

Conclusion

As cancer stem cell research rapidly transforms the global oncology landscape, this report equips executives with the evidence-based insights needed to drive innovation and strategic growth. Stakeholders will gain a clear path to capitalizing on opportunities and overcoming market complexities.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing clinical trial activity for Notch and Hedgehog pathway inhibitors targeting cancer stem cells
5.2. Rising adoption of CAR T cell therapies engineered to eliminate resistant cancer stem cell populations
5.3. Development of nanoparticle delivery platforms enhancing drug accumulation in cancer stem cell niches
5.4. Integration of single cell sequencing technologies to identify heterogeneity within cancer stem cells in clinical samples
5.5. Strategic partnerships between biotech firms and big pharma to accelerate cancer stem cell targeted drug development
5.6. Market entry of small molecule inhibitors targeting Wnt beta catenin signaling in cancer stem cell maintenance
5.7. Expansion of ex vivo organoid screening models for high throughput evaluation of cancer stem cell therapeutics
5.8. Increasing venture capital investments driving novel cancer stem cell therapy startups and platform technologies
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cancer Stem Cells Market, by Product Type
8.1. Introduction
8.2. Instruments
8.2.1. Cell Sorters
8.2.2. Flow Cytometers
8.2.3. Imaging Systems
8.3. Reagents & Kits
8.3.1. Culture Media & Supplements
8.3.2. Growth Factors & Cytokines
8.3.3. Markers & Antibodies
8.4. Services
8.4.1. Contract Research
8.4.2. Custom Assay Development
9. Cancer Stem Cells Market, by Application
9.1. Introduction
9.2. Cell Therapy Research
9.2.1. Clinical Trials
9.2.2. Preclinical Evaluation
9.3. Disease Modeling
9.3.1. In Vitro Modeling
9.3.2. In Vivo Modeling
9.4. Drug Discovery
9.4.1. High Throughput Screening
9.4.2. Lead Optimization
9.5. Toxicology Testing
9.5.1. Genotoxicity Assessment
9.5.2. In Vitro Toxicity
10. Cancer Stem Cells Market, by End Users
10.1. Introduction
10.2. Academic & Research Institutes
10.2.1. Research Institutes
10.2.2. University Labs
10.3. Biopharmaceutical Companies
10.3.1. Large Pharma
10.3.2. Small Biotech
10.4. Contract Research Organizations
10.4.1. Clinical Services
10.4.2. Preclinical Services
10.5. Hospitals & Clinics
11. Americas Cancer Stem Cells Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa Cancer Stem Cells Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific Cancer Stem Cells Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. Thermo Fisher Scientific, Inc.
14.3.2. Merck KGaA
14.3.3. Bio-Techne Corporation
14.3.4. STEMCELL Technologies Inc.
14.3.5. Miltenyi Biotec GmbH
14.3.6. Lonza Group AG
14.3.7. PromoCell GmbH
14.3.8. Abcam plc
14.3.9. Celprogen, Inc.
14.3.10. American Type Culture Collection (ATCC)
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. CANCER STEM CELLS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CANCER STEM CELLS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CANCER STEM CELLS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CANCER STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CANCER STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CANCER STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CANCER STEM CELLS MARKET SIZE, BY END USERS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CANCER STEM CELLS MARKET SIZE, BY END USERS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS CANCER STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 12. AMERICAS CANCER STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES CANCER STEM CELLS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 14. UNITED STATES CANCER STEM CELLS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. EUROPE, MIDDLE EAST & AFRICA CANCER STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CANCER STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC CANCER STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC CANCER STEM CELLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. CANCER STEM CELLS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 20. CANCER STEM CELLS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 21. CANCER STEM CELLS MARKET: RESEARCHAI
FIGURE 22. CANCER STEM CELLS MARKET: RESEARCHSTATISTICS
FIGURE 23. CANCER STEM CELLS MARKET: RESEARCHCONTACTS
FIGURE 24. CANCER STEM CELLS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CANCER STEM CELLS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CANCER STEM CELLS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CANCER STEM CELLS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CANCER STEM CELLS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CANCER STEM CELLS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CANCER STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CANCER STEM CELLS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CANCER STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CANCER STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CANCER STEM CELLS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CANCER STEM CELLS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CANCER STEM CELLS MARKET SIZE, BY CELL SORTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CANCER STEM CELLS MARKET SIZE, BY CELL SORTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CANCER STEM CELLS MARKET SIZE, BY FLOW CYTOMETERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CANCER STEM CELLS MARKET SIZE, BY FLOW CYTOMETERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CANCER STEM CELLS MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CANCER STEM CELLS MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CANCER STEM CELLS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CANCER STEM CELLS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CANCER STEM CELLS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CANCER STEM CELLS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CANCER STEM CELLS MARKET SIZE, BY CULTURE MEDIA & SUPPLEMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CANCER STEM CELLS MARKET SIZE, BY CULTURE MEDIA & SUPPLEMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CANCER STEM CELLS MARKET SIZE, BY GROWTH FACTORS & CYTOKINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CANCER STEM CELLS MARKET SIZE, BY GROWTH FACTORS & CYTOKINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CANCER STEM CELLS MARKET SIZE, BY MARKERS & ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CANCER STEM CELLS MARKET SIZE, BY MARKERS & ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CANCER STEM CELLS MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CANCER STEM CELLS MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CANCER STEM CELLS MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CANCER STEM CELLS MARKET SIZE, BY SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CANCER STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CANCER STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CANCER STEM CELLS MARKET SIZE, BY CUSTOM ASSAY DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CANCER STEM CELLS MARKET SIZE, BY CUSTOM ASSAY DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CANCER STEM CELLS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CANCER STEM CELLS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CANCER STEM CELLS MARKET SIZE, BY CELL THERAPY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CANCER STEM CELLS MARKET SIZE, BY CELL THERAPY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CANCER STEM CELLS MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CANCER STEM CELLS MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CANCER STEM CELLS MARKET SIZE, BY PRECLINICAL EVALUATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CANCER STEM CELLS MARKET SIZE, BY PRECLINICAL EVALUATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CANCER STEM CELLS MARKET SIZE, BY CELL THERAPY RESEARCH, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CANCER STEM CELLS MARKET SIZE, BY CELL THERAPY RESEARCH, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CANCER STEM CELLS MARKET SIZE, BY DISEASE MODELING, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CANCER STEM CELLS MARKET SIZE, BY DISEASE MODELING, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CANCER STEM CELLS MARKET SIZE, BY IN VITRO MODELING, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CANCER STEM CELLS MARKET SIZE, BY IN VITRO MODELING, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CANCER STEM CELLS MARKET SIZE, BY IN VIVO MODELING, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CANCER STEM CELLS MARKET SIZE, BY IN VIVO MODELING, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CANCER STEM CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CANCER STEM CELLS MARKET SIZE, BY DISEASE MODELING, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CANCER STEM CELLS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CANCER STEM CELLS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CANCER STEM CELLS MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CANCER STEM CELLS MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CANCER STEM CELLS MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CANCER STEM CELLS MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CANCER STEM CELLS MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CANCER STEM CELLS MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CANCER STEM CELLS MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CANCER STEM CELLS MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CANCER STEM CELLS MARKET SIZE, BY GENOTOXICITY ASSESSMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CANCER STEM CELLS MARKET SIZE, BY GENOTOXICITY ASSESSMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CANCER STEM CELLS MARKET SIZE, BY IN VITRO TOXICITY, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CANCER STEM CELLS MARKET SIZE, BY IN VITRO TOXICITY, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CANCER STEM CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CANCER STEM CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CANCER STEM CELLS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CANCER STEM CELLS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL CANCER STEM CELLS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL CANCER STEM CELLS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL CANCER STEM CELLS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL CANCER STEM CELLS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL CANCER STEM CELLS MARKET SIZE, BY UNIVERSITY LABS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL CANCER STEM CELLS MARKET SIZE, BY UNIVERSITY LABS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL CANCER STEM CELLS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL CANCER STEM CELLS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL CANCER STEM CELLS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL CANCER STEM CELLS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL CANCER STEM CELLS MARKET SIZE, BY LARGE PHARMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL CANCER STEM CELLS MARKET SIZE, BY LARGE PHARMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL CANCER STEM CELLS MARKET SIZE, BY SMALL BIOTECH, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL CANCER STEM CELLS MARKET SIZE, BY SMALL BIOTECH, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL CANCER STEM CELLS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL CANCER STEM CELLS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL CANCER STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL CANCER STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL CANCER STEM CELLS MARKET SIZE, BY CLINICAL SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL CANCER STEM CELLS MARKET SIZE, BY CLINICAL SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL CANCER STEM CELLS MARKET SIZE, BY PRECLINICAL SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL CANCER STEM CELLS MARKET SIZE, BY PRECLINICAL SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL CANCER STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL CANCER STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL CANCER STEM CELLS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL CANCER STEM CELLS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS CANCER STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS CANCER STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS CANCER STEM CELLS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS CANCER STEM CELLS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS CANCER STEM CELLS MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS CANCER STEM CELLS MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS CANCER STEM CELLS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS CANCER STEM CELLS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS CANCER STEM CELLS MARKET SIZE, BY CELL THERAPY RESEARCH, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS CANCER STEM CELLS MARKET SIZE, BY CELL THERAPY RESEARCH, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS CANCER STEM CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS CANCER STEM CELLS MARKET SIZE, BY DISEASE MODELING, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS CANCER STEM CELLS MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS CANCER STEM CELLS MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS CANCER STEM CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS CANCER STEM CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS CANCER STEM CELLS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS CANCER STEM CELLS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS CANCER STEM CELLS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS CANCER STEM CELLS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS CANCER STEM CELLS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS CANCER STEM CELLS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS CANCER STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS CANCER STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS CANCER STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS CANCER STEM CELLS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES CANCER STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES CANCER STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES CANCER STEM CELLS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES CANCER STEM CELLS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES CANCER STEM CELLS MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES CANCER STEM CELLS MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES CANCER STEM CELLS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES CANCER STEM CELLS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES CANCER STEM CELLS MARKET SIZE, BY CELL THERAPY RESEARCH, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES CANCER STEM CELLS MARKET SIZE, BY CELL THERAPY RESEARCH, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES CANCER STEM CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES CANCER STEM CELLS MARKET SIZE, BY DISEASE MODELING, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES CANCER STEM CELLS MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES CANCER STEM CELLS MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES CANCER STEM CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES CANCER STEM CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES CANCER STEM CELLS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES CANCER STEM CELLS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES CANCER STEM CELLS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES CANCER STEM CELLS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES CANCER STEM CELLS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES CANCER STEM CELLS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES CANCER STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES CANCER STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES CANCER STEM CELLS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES CANCER STEM CELLS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 157. CANADA CANCER STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 158. CANADA CANCER STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 159. CANADA CANCER STEM CELLS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 160. CANADA CANCER STEM CELLS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 161. CANADA CANCER STEM CELLS MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 162. CANADA CANCER STEM CELLS MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 163. CANADA CANCER STEM CELLS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 164. CANADA CANCER STEM CELLS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 165. CANADA CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 166. CANADA CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 167. CANADA CANCER STEM CELLS MARKET SIZE, BY CELL THERAPY RESEARCH, 2018-2024 (USD MILLION)
TABLE 168. CANADA CANCER STEM CELLS MARKET SIZE, BY CELL THERAPY RESEARCH, 2025-2030 (USD MILLION)
TABLE 169. CANADA CANCER STEM CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2024 (USD MILLION)
TABLE 170. CANADA CANCER STEM CELLS MARKET SIZE, BY DISEASE MODELING, 2025-2030 (USD MILLION)
TABLE 171. CANADA CANCER STEM CELLS MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 172. CANADA CANCER STEM CELLS MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 173. CANADA CANCER STEM CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2024 (USD MILLION)
TABLE 174. CANADA CANCER STEM CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2025-2030 (USD MILLION)
TABLE 175. CANADA CANCER STEM CELLS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 176. CANADA CANCER STEM CELLS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 177. CANADA CANCER STEM CELLS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 178. CANADA CANCER STEM CELLS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 179. CANADA CANCER STEM CELLS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 180. CANADA CANCER STEM CELLS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 181. CANADA CANCER STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 182. CANADA CANCER STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 183. MEXICO CANCER STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 184. MEXICO CANCER STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 185. MEXICO CANCER STEM CELLS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 186. MEXICO CANCER STEM CELLS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 187. MEXICO CANCER STEM CELLS MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 188. MEXICO CANCER STEM CELLS MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 189. MEXICO CANCER STEM CELLS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 190. MEXICO CANCER STEM CELLS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 191. MEXICO CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 192. MEXICO CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 193. MEXICO CANCER STEM CELLS MARKET SIZE, BY CELL THERAPY RESEARCH, 2018-2024 (USD MILLION)
TABLE 194. MEXICO CANCER STEM CELLS MARKET SIZE, BY CELL THERAPY RESEARCH, 2025-2030 (USD MILLION)
TABLE 195. MEXICO CANCER STEM CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2024 (USD MILLION)
TABLE 196. MEXICO CANCER STEM CELLS MARKET SIZE, BY DISEASE MODELING, 2025-2030 (USD MILLION)
TABLE 197. MEXICO CANCER STEM CELLS MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 198. MEXICO CANCER STEM CELLS MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 199. MEXICO CANCER STEM CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2024 (USD MILLION)
TABLE 200. MEXICO CANCER STEM CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2025-2030 (USD MILLION)
TABLE 201. MEXICO CANCER STEM CELLS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 202. MEXICO CANCER STEM CELLS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 203. MEXICO CANCER STEM CELLS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 204. MEXICO CANCER STEM CELLS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 205. MEXICO CANCER STEM CELLS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 206. MEXICO CANCER STEM CELLS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 207. MEXICO CANCER STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 208. MEXICO CANCER STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL CANCER STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL CANCER STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL CANCER STEM CELLS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL CANCER STEM CELLS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL CANCER STEM CELLS MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL CANCER STEM CELLS MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL CANCER STEM CELLS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL CANCER STEM CELLS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL CANCER STEM CELLS MARKET SIZE, BY CELL THERAPY RESEARCH, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL CANCER STEM CELLS MARKET SIZE, BY CELL THERAPY RESEARCH, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL CANCER STEM CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL CANCER STEM CELLS MARKET SIZE, BY DISEASE MODELING, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL CANCER STEM CELLS MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL CANCER STEM CELLS MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL CANCER STEM CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL CANCER STEM CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL CANCER STEM CELLS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL CANCER STEM CELLS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL CANCER STEM CELLS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL CANCER STEM CELLS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL CANCER STEM CELLS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL CANCER STEM CELLS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL CANCER STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL CANCER STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA CANCER STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA CANCER STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA CANCER STEM CELLS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA CANCER STEM CELLS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA CANCER STEM CELLS MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA CANCER STEM CELLS MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA CANCER STEM CELLS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA CANCER STEM CELLS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA CANCER STEM CELLS MARKET SIZE, BY CELL THERAPY RESEARCH, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA CANCER STEM CELLS MARKET SIZE, BY CELL THERAPY RESEARCH, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA CANCER STEM CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA CANCER STEM CELLS MARKET SIZE, BY DISEASE MODELING, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA CANCER STEM CELLS MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA CANCER STEM CELLS MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA CANCER STEM CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA CANCER STEM CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA CANCER STEM CELLS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA CANCER STEM CELLS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA CANCER STEM CELLS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA CANCER STEM CELLS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 257. ARGENTINA CANCER STEM CELLS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 258. ARGENTINA CANCER STEM CELLS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 259. ARGENTINA CANCER STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 260. ARGENTINA CANCER STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA CANCER STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA CANCER STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA CANCER STEM CELLS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA CANCER STEM CELLS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA CANCER STEM CELLS MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA CANCER STEM CELLS MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA CANCER STEM CELLS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA CANCER STEM CELLS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA CANCER STEM CELLS MARKET SIZE, BY CELL THERAPY RESEARCH, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA CANCER STEM CELLS MARKET SIZE, BY CELL THERAPY RESEARCH, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA CANCER STEM CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA CANCER STEM CELLS MARKET SIZE, BY DISEASE MODELING, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA CANCER STEM CELLS MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA CANCER STEM CELLS MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA CANCER STEM CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA CANCER STEM CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2025-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA CANCER STEM CELLS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA CANCER STEM CELLS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA CANCER STEM CELLS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA CANCER STEM CELLS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA CANCER STEM CELLS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA CANCER STEM CELLS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA CANCER STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA CANCER STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA CANCER STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA CANCER STEM CELLS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM CANCER STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 290. UNITED KINGDOM CANCER STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM CANCER STEM CELLS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 292. UNITED KINGDOM CANCER STEM CELLS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM CANCER STEM CELLS MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 294. UNITED KINGDOM CANCER STEM CELLS MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM CANCER STEM CELLS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 296. UNITED KINGDOM CANCER STEM CELLS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 297. UNITED KINGDOM CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 298. UNITED KINGDOM CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 299. UNITED KINGDOM CANCER STEM CELLS MARKET SIZE, BY CELL THERAPY RESEARCH, 2018-2024 (USD MILLION)
TABLE 300. UNITED KINGDOM CANCER STEM CELLS MARKET SIZE, BY CELL THERAPY RESEARCH, 2025-2030 (USD MILLION)
TABLE 301. UNITED KINGDOM CANCER STEM CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2024 (USD MILLION)
TABLE 302. UNITED KINGDOM CANCER STEM CELLS MARKET SIZE, BY DISEASE MODELING, 2025-2030 (USD MILLION)
TABLE 303. UNITED KINGDOM CANCER STEM CELLS MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 304. UNITED KINGDOM CANCER STEM CELLS MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 305. UNITED KINGDOM CANCER STEM CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2018-2024 (USD MILLION)
TABLE 306. UNITED KINGDOM CANCER STEM CELLS MARKET SIZE, BY TOXICOLOGY TESTING, 2025-2030 (USD MILLION)
TABLE 307. UNITED KINGDOM CANCER STEM CELLS MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 308. UNITED KINGDOM CANCER STEM CELLS MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 309. UNITED KINGDOM CANCER STEM CELLS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 310. UNITED KINGDOM CANCER STEM CELLS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 311. UNITED KINGDOM CANCER STEM CELLS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 312. UNITED KINGDOM CANCER STEM CELLS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 313. UNITED KINGDOM CANCER STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 314. UNITED KINGDOM CANCER STEM CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 315. GERMANY CANCER STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 316. GERMANY CANCER STEM CELLS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 317. GERMANY CANCER STEM CELLS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 318. GERMANY CANCER STEM CELLS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 319. GERMANY CANCER STEM CELLS MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 320. GERMANY CANCER STEM CELLS MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 321. GERMANY CANCER STEM CELLS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 322. GERMANY CANCER STEM CELLS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 323. GERMANY CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 324. GERMANY CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 325. GERMANY CANCER STEM CELLS MARKET SIZE, BY CELL THERAPY RESEARCH, 2018-2024 (USD MILLION)
TABLE 326. GERMANY CANCER STEM CELLS MARKET SIZE, BY CELL THERAPY RESEARCH, 2025-2030 (USD MILLION)
TABLE 327. GERMANY CANCER STEM CELLS MARKET SIZE, BY DISEASE MODELING, 2018-2024 (USD MILLION)
TABLE 328. GERMANY CANCER STEM CELLS MARKET S

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Cancer Stem Cells market report include:
  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Bio-Techne Corporation
  • STEMCELL Technologies Inc.
  • Miltenyi Biotec GmbH
  • Lonza Group AG
  • PromoCell GmbH
  • Abcam plc
  • Celprogen, Inc.
  • American Type Culture Collection (ATCC)

Table Information

Report AttributeDetails
No. of Pages192
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 5.77 Billion
Forecasted Market Value ( USD ) by 2030 $ 9.55 Billion
Compound Annual Growth Rate10.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Cancer Stem Cells - Global Strategic Business Report - Product Image

Cancer Stem Cells - Global Strategic Business Report

  • Report
  • 282 Pages
  • Global
From
Cancer Stem Cells Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Cancer Stem Cells Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
2025 Global Forecast for Circulating Tumor Cells And Cancer Stem Cells Market (2026-2031 Outlook)-High Tech Outlook Report - Product Image

2025 Global Forecast for Circulating Tumor Cells And Cancer Stem Cells Market (2026-2031 Outlook)-High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From
Autologous Stem Cell and Non-Stem Cell Therapies Market Report and Forecast 2025-2034 - Product Image

Autologous Stem Cell and Non-Stem Cell Therapies Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
North America Stem Cell Assay Market Report and Forecast 2025-2034 - Product Image

North America Stem Cell Assay Market Report and Forecast 2025-2034

  • Report
  • 250 Pages
  • North America
From

About the Cancer Stem Cell Market

The Cancer Stem Cell (CSC) market is a subset of the larger stem cell market. CSCs are a type of stem cell that can cause cancer when they divide and grow uncontrollably. CSCs are believed to be responsible for the recurrence of cancer after treatment, and are the focus of much research into new treatments. CSCs are also being studied for their potential to be used in regenerative medicine. CSCs are being studied for their potential to be used in personalized medicine, where treatments are tailored to the individual patient. CSCs are also being studied for their potential to be used in drug discovery and development, as they can be used to test the effectiveness of new drugs. The CSC market is a rapidly growing field, with many companies investing in research and development. Companies such as Celgene, Novartis, and AstraZeneca are investing in CSC research, while companies such as Thermo Fisher Scientific and Bio-Rad are providing tools and services to support CSC research. Other companies such as StemCell Technologies and STEMCELL Technologies are providing products and services to support CSC research. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.